Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,064.29 -23.09 (-2.12%)
Official Closing Price Updated: 7:00 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Prediction: This Healthcare Stock Could Soar by 72% in 2026 ↗
And the share price appreciation could happen pretty soon. 
Via The Motley Fool
News headline image
Down 55%, Should You Buy the Dip on Pfizer? ↗
Pfizer's stock has started to turn higher, but it is still down massively; is now the time to jump aboard? 
Via The Motley Fool
Topics Intellectual Property
News headline image
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗
Via MarketBeat
Topics ETFs
News headline image
Silicon Meets Science: NVIDIA and Eli Lilly Launch $1 Billion AI Lab to Engineer the Future of Medicine
In a move that signals a paradigm shift for the pharmaceutical industry, NVIDIA (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) have announced the launch of a $1 billion joint AI co-innovation... 
Via TokenRing AI
Topics Artificial Intelligence
NVO Shares Rise On Strong Kickstart For Wegovy Pill In US: Retail Eyes Up To $110 As ‘Fair Value’ ↗
Via Stocktwits
News headline image
The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever ↗
All three of these healthcare giants are leaders in their niches. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins
As of January 19, 2026, the pharmaceutical landscape is being redefined by a single name: Eli Lilly and Company (NYSE: LLY). Once a steady, century-old stalwart known for its dominance in the insulin... 
Via Finterra
Topics Economy
News headline image
The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature
As of January 19, 2026, Johnson & Johnson (NYSE: JNJ) stands as a radically different enterprise than the one most investors recognized just three years ago. Following the successful spin-off of its... 
Via Finterra
Topics Artificial Intelligence Bankruptcy Economy
News headline image
Prediction: 2026 Will Be the Year of Eli Lilly ↗
A catalyst lies just ahead. 
Via The Motley Fool
News headline image
Should Investors Worry About Regional Banks After One Firm Dumped 1.8 Million Western Alliance Shares? ↗
Western Alliance Bancorporation delivers commercial and consumer banking solutions across key western U.S. markets. 
Via The Motley Fool
This Is My No. 1 Recommended Vanguard ETF to Buy in 2026 ↗
The stars could be aligning for healthcare stocks this year. This Vanguard ETF is a great way to play it. 
Via The Motley Fool
Topics ETFs Economy
News headline image
Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? ↗
The pharmaceutical leader has plenty of cash and is using it effectively. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Why a $6 Million Allocation to Short-Dated Credit Stands Out Right Now ↗
The Invesco BulletShares 2026 Corporate Bond ETF targets investment grade U.S. corporate bonds maturing in 2026 with a defined maturity profile. 
Via The Motley Fool
Topics Bonds ETFs Regulatory Compliance
News headline image
This Company Is Doubling Down on AI. Is the Stock a Buy? ↗
The pharmaceutical leader continues to grab headlines. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Eli Lilly: A Strong Player in the Pharmaceutical Arena ↗
Join us as we explore Eli Lilly's impressive market position and financial health. Discover why this pharmaceutical giant is capturing investor attention and what the future may hold for its stock. 
Via The Motley Fool
News headline image
The Atomic Revolution: How AlphaFold 3 is Redefining the Future of Medicine
In a milestone that many researchers are calling the "biological equivalent of the moon landing," AlphaFold 3 has officially moved structural biology into a new era of predictive precision. Developed... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? ↗
The choice isn't that hard. 
Via The Motley Fool
News headline image
The $5.1 Trillion Wave: Why 2026 is Set to Become the Biggest Year for Global M&A
As the global economy shakes off the final remnants of the high-interest-rate era, a massive wave of consolidation is sweeping through corporate boardrooms. Analysts have officially adjusted their... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Nvidia and Eli Lilly Are Partnering on a $1 Billion Lab. Here's What Investors Need to Know. ↗
The high-powered duo is teaming up to build and equip a $1 billion research facility in California. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Tema ETFs Adds $8 Million to an Industrial Stock Up 63% This Past Year ↗
Powell Industries designs and manufactures custom electrical systems for critical infrastructure in heavy industry and utilities worldwide. 
Via The Motley Fool
Topics ETFs Regulatory Compliance
News headline image
Why A 'Solid' First Week For Oral Wegovy Bodes Well For Novo And Lilly ↗
Novo Nordisk's oral Wegovy snagged 3,071 prescriptions in its first week on the market, an analyst said Friday. 
Via Investor's Business Daily
News headline image
Eli Lilly Shares Near Highs As Score Flags Momentum Ahead Of Earnings ↗
Eli Lilly's stock experiences strong momentum prior to its upcoming earnings report, supported by robust analyst targets and a solid growth narrative, despite recent volatility. 
Via Talk Markets
Chips and Checks: AI and Banks Lead Wall Street's Charge ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
3 Unstoppable Stocks to Buy in 2026 and Hold Forever ↗
These stocks are leaders in their respective industries, and they have excellent fundamentals. 
Via The Motley Fool
Topics Artificial Intelligence Credit Cards
News headline image
"Animal Spirits" Return: Morgan Stanley Signals M&A Renaissance as Healthcare and Industrials Lead Shifting Landscape
As 2026 begins, the global mergers and acquisitions (M&A) market is witnessing a profound "renaissance," driven by a confluence of stabilizing interest rates, record levels of corporate cash, and a... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
The Great Broadening: Why the S&P 500 Rally Is No Longer Just a Tech Story
As we enter the first weeks of 2026, the narrative of a stock market dominated by a handful of tech giants has finally given way to a more balanced and resilient economic landscape. For the first time... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The Dealmaking Renaissance: Goldman Sachs and Morgan Stanley Signal a 2026 M&A Surge as Fees Skyrocket
The "long winter" of corporate dealmaking has officially thawed, giving way to a robust spring of activity that promises to redefine the financial landscape in 2026. As of January 15, 2026, the Fourth... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
The Atomic Revolution: How AlphaFold 3’s Open-Source Pivot Has Redefined Global Drug Discovery in 2026
The decision by Google DeepMind and its commercial sister company, Isomorphic Labs, to fully open-source AlphaFold 3 (AF3) has emerged as a watershed moment for the life sciences. As of January 2026,... 
Via TokenRing AI
Topics Artificial Intelligence Derivatives Economy
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
The Silicon Laureates: How the 2024 Nobel Prizes Cemented AI as the New Language of Science
The announcement of the 2024 Nobel Prizes in Physics and Chemistry sent a shockwave through the global scientific community, signaling a definitive end to the "AI Winter" and the beginning of what... 
Via TokenRing AI
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.